secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeMD, Inc. (LFMD)
CIK:        0000948320
Form:       8-K
Filed at:   2022-12-21T23:59:59+00:00
Accession:  0001493152-22-036130
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeMD appoints Kathleen E. Walsh to Board; grants 75,000 restricted shares and 37,500 stock options
--------------------------------------------------------------------------------

- Kathleen E. Walsh appointed to Board on Dec 15, 2022; she is President & CEO of Boston Medical Center.
- Received 75,000 restricted shares (37,500 vest immediately, 37,500 vest in 2 years).
- Also received option to purchase 37,500 shares, vesting in 2 years.
- Will receive $6,000 per quarter as Board compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/948320/000149315222036130/0001493152-22-036130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/948320/000149315222036130/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-036130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer